Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease;Tau-protein-spiegel in der diagnostik der Alzheimer-Demenz

Fortschritte der Neurologie Psychiatrie

Volumn 68, Issue 10, 2000, Pages 439-446

  Schonknecht, P ^a   Pantel, J ^a   Werle, E ^a   Hartmann, T ^a   Essig, M ^b   Baudendistel, K ^b   Beyreuther, K ^a   Schroder, J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRESENILE DEMENTIA;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; DEMENTIA, VASCULAR; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; TAU PROTEINS;

EID: 0033736343     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-7732     Document Type: Article

References (46)

1. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: A community follow up study
2. Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
3. Tau in cerebrospinal fluid: A potential diagnostik marker in Alzheimer's disease
4. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: Implications for the clinical diagnosis of Alzheimer's disease
5. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
6. Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memory-impaired individuals
7. No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia
8. Tau protein in cerebrospinal fluid - A biochemical marker for axonal degeneration in Alzheimer disease?
9. Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipo-protein E allele epsilon 4 during 14 months follow-up
10. Tau-Protein - Ein potentieller biologischer indikator zur fruherkennung der alzheimer-krankheit
11. 'Mini Mental State'. A practical method for grading the cognitive state of patients for the clinicians
12. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer's disease and relation to apolipoprotein E genotyp
13. Dependence of cerebrospinal fluid tau protein levels on apolipo-protein E4 allele frequency in patients with Alzheimer's disease
14. Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease
15. Aktuelle moglichkeiten und perspektiven der liquoruntersuchung bei der Alzheimer demenz
16. Increased levels of τ protein in cerebrospinal fluid of patients with Alzheimer's disease - Correlation with degree of cognitive impairment
17. Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
18. Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease
19. Diagnostic accuracy of Alzheimer's disease: A clinicopathological study
20. Increased cerebrospinal fluid tau in patients with Alzheimer's disease
21. Longitudinal study of cerebrospinal fluid levels of tau, Aβ 1-40, and Aβ 1-42(43) in Alzheimer's disease: A study in Japan
22. Diagnostic accuracy of Alzheimer's disease: A neuropathological study
23. Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein
24. Diagnostic evaluation of degenerative and vascular dementia
25. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease
26. Tau protein in cerebrospinal fluid: A new diagnostic and prognostic marker in Alzheimer disease?
27. Tau in cerebrospinal fluids: Establishment of the sandwich EUSA with antibody specific to the repeat sequences in tau
28. Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics
29. Reduction of β-amyloid-peptid 42 in the cerebrospinal fluid of patients with Alzheimer's disease
30. Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease
31. Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: Multi-center study in Japan
32. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
33. Quantitative magnetresonanztomographie und schweregrad der defizite bei der demenz vom Alzheimer-typ
34. Quantitative magnetic resonance imaging and neuropsychological functions in dementia of the Alzheimer type
35. The global deterioration scale (GDS): An instrument for the assessment of primary degenerative dementia (PDD)
36. Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase
37. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
38. Cerebral changes and cerebrospinal fluid β-amyloid in Alzheimer's disease: A study with quantitative magnetic resonance imaging
39. Morphologische und funktionelle bildgebung
40. Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease
41. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: Relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele
42. CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease
43. Tau protein concer trations in cerebrospinal fluid of patients with dementia of the Alzheimer type
44. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease
45. Apolipoprotein E genotyping by onestage PCR